abstract |
The present invention relates to immunogenic compositions useful for preventing and treating Staphylococcus aureus infection. The invention further relates to multivalent oligopeptides, fusion proteins comprising two or more staphylococcal superantigen (SAg) proteins, or any fragment, variant, derivative or mutant thereof fused together in the form of of a single polypeptide in any order. |